Ledger.Open graph →
SEC Form D · filed February 2, 2023

Secretome Therapeutics, Inc

Offering
$10.9M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Henrik Rasmussen · DALLAS, TXDirectorAngela Shen · DALLAS, TXDirectorVineet Jindal · DALLAS, TXExec · DirectorSunjay Kaushal · DALLAS, TXDirectorWilliam Niland · Stevensville, MDDirectorHenrik Rasmussen · DALLAS, TXDirectorAngela Shen · DALLAS, TXDirectorVineet Jindal · DALLAS, TXExec · DirectorSunjay Kaushal · DALLAS, TXDirectorWilliam Niland · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗